<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03689881</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL18_0328</org_study_id>
    <nct_id>NCT03689881</nct_id>
  </id_info>
  <brief_title>Value of Tomosynthesis for the Detection of Sacro-iliitis (TOMOS SI)</brief_title>
  <acronym>TOMOS SI</acronym>
  <official_title>Value of Tomosynthesis for Detection of Sacro-iliitis: a Prospective Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DMS Apelem</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Thales</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Digisens</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medecom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>BPIfrance</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>European Regional Development Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spondyloarthropathies (SpAs) are chronic inflammatory diseases encompassing ankylosing&#xD;
      spondylitis, psoriatic arthritis, reactive arthritis, enteropathic arthropathy, and&#xD;
      undifferentiated SpA.&#xD;
&#xD;
      In 2001, the estimated prevalence of SpA was 1.5% worldwide. Sacroiliitis is a condition&#xD;
      caused by inflammation within the sacroiliac joint. It is the most frequent damage of SpA&#xD;
      depicted at imaging evaluation.&#xD;
&#xD;
      Conventional radiography (X-ray) is usually used to depict the structural changes associated&#xD;
      with sacroiliitis.&#xD;
&#xD;
      However further evaluation often requires additionnal computed tomography (CT).&#xD;
&#xD;
      Tomosynthesis is an Xray-based imaging technology which allows reconstruction of multiple&#xD;
      section images from a set of projection images acquired as the x-ray tube moves along a&#xD;
      prescribed path. The advantagee of tomosynthesis is the significant reduction of radiation&#xD;
      dose exposure compared to CT Tomosynthesis is currently used in the field of breast imaging&#xD;
      and pneumology. Very few studies have examined the value of tomosynthesis for osteoarticular&#xD;
      imaging.&#xD;
&#xD;
      The study aims at evaluating the diagnostic performances of tomosynthesis as compared to&#xD;
      standard X-ray and CT, in patients with a clinical suspicion of sacroiliitis.&#xD;
&#xD;
      the investigators hypothesize that tomosynthesis is superior to conventional radiography for&#xD;
      detection of sacroiliitis and is at least equal to CT with lower irradiation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Consecutive patients referred to CT for exploration of sacrollitis will be included and&#xD;
      investigated with standard radiography, CT and tomosynthesis of SI joints.&#xD;
&#xD;
      Imaging examinations will be performed at day of enrollment as follow : X-ray and CT as&#xD;
      standard management and tomosynthesis as additional evaluation. CT will be considered as the&#xD;
      reference standard Sacroiliitis will be assessed in a centralized, blind and randomized&#xD;
      retrospective reading of all imaging modalities by two independent radiologists.&#xD;
&#xD;
      Diagnostic performances and radiation doses of tomosynthesis will be compared to those of&#xD;
      standard CT and X-ray examinations.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">October 4, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of bone erosions and other structural lesions of SI joints</measure>
    <time_frame>1 day of enrollment</time_frame>
    <description>sacroiliitis will be assessed independently for each imaging modality according to the modified New York criteria</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>radiation dose</measure>
    <time_frame>1 day of enrollment</time_frame>
    <description>Radiation dose will be measured for each imaging evaluation and calculated as the effective dose in millisievert (mSv).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inter reader agreement for the evaluation of sacroiliitis at tomosynthesis</measure>
    <time_frame>at the end of patients enrollment</time_frame>
    <description>Inter reader agreement will be measured at retrospective evaluation.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Sacroiliitis</condition>
  <arm_group>
    <arm_group_label>Tomosynthesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tomosynthesis of SI joints</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tomosynthesis of SI joints</intervention_name>
    <description>All patients will undergo additional tomosynthesis performed per study protocol along with Xray and CT performed as part of standard imaging evaluation of sacroillitis.&#xD;
Tomosynthesis of SI joints will be performed on a digital Tomosynthesis system (PLATINUM dRF v2 DMS/APELEM), with a single acquisition followed by coronal image reconstruction.</description>
    <arm_group_label>Tomosynthesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 18 and over referred for suspected sacroiliitis.&#xD;
&#xD;
          -  Patients who have entered into their participation agreement by signing the informed&#xD;
             consent form.&#xD;
&#xD;
          -  Patient affiliated to a social security scheme or beneficiary.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or lactating women.&#xD;
&#xD;
          -  Vulnerable people according.&#xD;
&#xD;
          -  Major people placed under guardianship or curatorship.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine Cyteval, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montpellier University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Catherine Cyteval, MD, PhD</last_name>
    <phone>+ 33 4 67 33 81 78</phone>
    <email>c-cyteval@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Imaging department- University hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Lefebvre</last_name>
      <phone>+33 4 67 33 86 07</phone>
      <email>s-lefebvre@chu-montpellier.fr</email>
    </contact>
    <contact_backup>
      <last_name>Celine Engrand</last_name>
      <phone>+33 4 67 33 86 07</phone>
      <email>c-engrand@chu-montpellier.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 27, 2018</study_first_submitted>
  <study_first_submitted_qc>September 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2018</study_first_posted>
  <last_update_submitted>September 26, 2019</last_update_submitted>
  <last_update_submitted_qc>September 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sacroiliitis</keyword>
  <keyword>SI joint</keyword>
  <keyword>tomosynthesis</keyword>
  <keyword>CT</keyword>
  <keyword>Xray</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sacroiliitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

